Clinical Trial: Intravenous Thrombolysis, Endovascular Treatment, or Bridging Therapy for Medium Vessel Occlusion Stroke Within 24 Hours

U.S., Nov. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07931807) titled 'Intravenous Thrombolysis, Endovascular Treatment, or Bridging Therapy for Medium Vessel Occlusion Stroke Within 24 Hours' on Nov. 06.

Brief Summary: This trial compares intravenous thrombolysis (IVT) alone, endovascular treatment (EVT) alone, and bridging therapy (IVT followed immediately by EVT) in patients with acute ischemic stroke due to medium vessel occlusion (MeVO) and a baseline National Institutes of Health Stroke Scale (NIHSS) score >=6. The hypotheses are that EVT alone and bridging therapy each increase the proportion of patients with functional independence at 90 days compared with IVT alone. This is a multicenter, pros...